Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: The Use of Memantine for Prevention of Alzheimer's Disease [Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 2 clinical trial evaluating memantine for prevention of Alzheimer's disease, currently listed as ACTIVE_NOT_RECRUITING at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: University of Virginia | Conditions: Alzheimer Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING